TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18588670

Group type: COMPARATOR
Intervention: Medical practice group
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Independent researcher group
Number of subjects: 274
Study: 15801995

Group type: EXPERIMENTAL
Intervention: Clarithromycin extended-release (ER) 1000 mg once daily for 5 days
Number of subjects: 485

Group type: COMPARATOR
Intervention: Clarithromycin immediate-release (IR) 500 mg twice daily for 7 days
Number of subjects: 485
Study: 11929392

Group type: EXPERIMENTAL
Intervention: Cisapride, 10 mg q.d.s.
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10385713

Group type: COMPARATOR
Intervention: Ligation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined ligation and sclerotherapy
Number of subjects: 60
Study: 8873692

Group type: EXPERIMENTAL
Intervention: Normal sodium diet (240 mEq/day)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low sodium diet (20 mEq/day)
Number of subjects: 13
Study: 2028396

Group type: EXPERIMENTAL
Intervention: Postoperative telecobalt therapy
Number of subjects: 54

Group type: COMPARATOR
Intervention: Postoperative electron therapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: ECG
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 54
Study: 6984983

Group type: EXPERIMENTAL
Intervention: Cold cardioplegia with external cardiac cooling
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ischaemic arrest with mild systemic cooling to 32 degrees C
Number of subjects: 50
Study: 31661034

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) by intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) involving 7 Gy × 3 fractions to the whole involved vertebra + 10 Gy × 3 fractions on the gross tumor volume (GTV)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard conventional radiotherapy involving 4 Gy × 5 fractions to the whole involved vertebra
Number of subjects: 330
Study: 29489581

Group type: EXPERIMENTAL
Intervention: Socket shield technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional insertion technique
Number of subjects: 0
Study: 26652921

Group type: EXPERIMENTAL
Intervention: Buccal translation of maxillary first premolar with 50 g of force
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (non-moved maxillary first premolar)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Buccal translation intervention
Number of subjects: 11
Study: 25437588

Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine gluconate (CHG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 100
Study: 22965457

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 75

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 75
Study: 20510026

Group type: EXPERIMENTAL
Intervention: Advanced airway management
Number of subjects: 41

Group type: COMPARATOR
Intervention: Conventional systemic therapy and management of airway (Control)
Number of subjects: 41
Study: 17580145

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC-MPS) with cyclosporine microemulsion
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Enteric-coated mycophenolate sodium (EC-MPS)
Number of subjects: 456
Study: 16383040

Group type: EXPERIMENTAL
Intervention: 1 g/100 cm2 Dermlin topical application
Number of subjects: 90

Group type: COMPARATOR
Intervention: Topical application of silver sulfadiazine (SD - Ag) cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1 g/100 cm2 Dermlin treatment for diabetic foot ulcers
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Cell culture with 20 g/L Dermlin
Number of subjects: 90

Group type: COMPARATOR
Intervention: Topical application of silver sulfadiazine (SD - Ag) cream in animal test
Number of subjects: 90
Study: 12031758

Group type: EXPERIMENTAL
Intervention: CR oxycodone 10 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 10082174

Group type: EXPERIMENTAL
Intervention: Sustained release capsule (300 mg sodium valproate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral solution (300 mg sodium valproate)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Enteric-coated tablet (300 mg sodium valproate)
Number of subjects: 24
Study: 7788460

Group type: EXPERIMENTAL
Intervention: Social skills training
Number of subjects: 33

Group type: COMPARATOR
Intervention: Social milieu treatment
Number of subjects: 33
Study: 2140609

Group type: EXPERIMENTAL
Intervention: Intragastric load of glucose
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Naltrexone (25 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Basal plasma beta endorphin level
Number of subjects: 6

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 6
Study: 6816315

Group type: COMPARATOR
Intervention: TAM alone
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TAM + FT
Number of subjects: 82
Study: 31658070

Group type: EXPERIMENTAL
Intervention: Vojta approach
Number of subjects: 13

Group type: COMPARATOR
Intervention: General exercise
Number of subjects: 13
Study: 30308612

Group type: EXPERIMENTAL
Intervention: Robot-assisted minimally invasive thoracolaparoscopic esophagectomy (RAMIE)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Open transthoracic esophagectomy (OTE)
Number of subjects: 112
Study: 28182908

Group type: EXPERIMENTAL
Intervention: Training the social skill 'being able to demand'
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Training the social skill 'being able to say no'
Number of subjects: 40
Study: 25782365

Group type: EXPERIMENTAL
Intervention: Topical capsaicin application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thermal grill (TG) after capsaicin application
Number of subjects: 80

Group type: COMPARATOR
Intervention: Thermal grill (TG) after vehicle control (ethanol) application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Paradoxical heat sensation (PHS) after capsaicin application
Number of subjects: 80

Group type: COMPARATOR
Intervention: Paradoxical heat sensation (PHS) after control application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Detection thresholds to cold and warm after capsaicin application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thermal pain threshold after capsaicin application
Number of subjects: 80
Study: 23369724

Group type: EXPERIMENTAL
Intervention: Life! program intervention (structured group sessions based on the Health Action Process Approach model)
Number of subjects: 796

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 796
Study: 21319914

Group type: EXPERIMENTAL
Intervention: Extinguishing a blocking cue (A-) after training with A+ and AX+
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no preceding training with blocking cue A)
Number of subjects: 0
Study: 20054084

Group type: EXPERIMENTAL
Intervention: Animated model (Group A)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Text and line drawings (Group B)
Number of subjects: 74
Study: 20217203

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg loading dose administered 24 h before PCI)
Number of subjects: 299
Study: 16162709

Group type: EXPERIMENTAL
Intervention: Combined therapy (hyperpnea training + endurance training)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Endurance training
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study: 12095312

Group type: EXPERIMENTAL
Intervention: 4-Phenylbutyrate (Buphenyl) at doses of 20, 30, or 40 g divided t.i.d. for 1 week
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 10726022

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin 50 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anagrelide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7774076

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (no EPO)
Number of subjects: 67
Study: 2078806

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 38175

Group type: EXPERIMENTAL
Intervention: Three drugs in widespread clinical use for Crohn's disease (specific drugs not mentioned)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Prednisone (adjusted dose based on illness severity)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Standard clinical grading system (CDAI)
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Wilcoxon nonparametric statistics and life-table methods for analysis
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Overall compliance and completion rates
Number of subjects: 604
Study: 12424539

Group type: EXPERIMENTAL
Intervention: Negative immunomagnetic purging
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unpurged bone marrow support (historical control)
Number of subjects: 20
Study: 31614036

Group type: EXPERIMENTAL
Intervention: Endometrial thickness (ET) measurements
Number of subjects: 38105
Study: 30424818

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) programme
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Quality Improvement (QI) intervention
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Care pathway processes
Number of subjects: 93
Study: 27775407

Group type: EXPERIMENTAL
Intervention: Ingroup members' emotional expressions (e.g., fearful, happy, neutral)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingroup happy expressions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingroup expressions of fear
Number of subjects: 0

Group type: COMPARATOR
Intervention: Outgroup emotion trajectories
Number of subjects: 0
Study: 24780615

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) 700‐1000 mg iron (according to calculated iron deficit on postoperative day 2)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Ferrous glycine sulphate (FS) 100 mg iron daily from day 7 onwards
Number of subjects: 122
Study: 22700243

Group type: EXPERIMENTAL
Intervention: Proselfs granted voice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proselfs denied voice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocials granted voice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocials denied voice
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-voice procedures applied consistently between persons
Number of subjects: 0
Study: 20305572

Group type: EXPERIMENTAL
Intervention: Clinically elevated teacher ratings of inattentive symptoms
Number of subjects: 79
Study: 19102343

Group type: EXPERIMENTAL
Intervention: Straight anastomosis without ileostomy (Group A)
Number of subjects: 256

Group type: COMPARATOR
Intervention: Straight anastomosis with loop ileostomy (Group B)
Number of subjects: 256
Study: 15733766

Group type: EXPERIMENTAL
Intervention: Hands-Off Technique
Number of subjects: 13

Group type: COMPARATOR
Intervention: Standard Hand Position
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Two-Finger Fulcrum Technique
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Five-Finger Fulcrum Technique
Number of subjects: 13
Study: 11805508

Group type: EXPERIMENTAL
Intervention: Microkeratome-based limbal harvester with 170 microm head
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microkeratome-based limbal harvester with 200 microm head
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard microkeratomes for corneal lamellar cuts
Number of subjects: 0
Study: 10528328

Group type: EXPERIMENTAL
Intervention: New dopaminergic agonists (carbergolin, pramipexol, ropinirol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Catechol-O-methyl-transferase (COMT) inhibitors (entacapone, tolcapone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bromocryptin
Number of subjects: 0
Study: 7579497

Group type: EXPERIMENTAL
Intervention: Mammography screening (not specified dosage or duration)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Interview with nonattenders
Number of subjects: 211
Study: 1702663

Group type: EXPERIMENTAL
Intervention: 300 micrograms of selenium in high Se malt cakes daily for one year
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo of malt cakes daily for one year
Number of subjects: 40
Study: 381876

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 30700615

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided suprainguinal fascia iliaca compartment block (SFICB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Periarticular infiltration (PAI)
Number of subjects: 60
Study: 30160651

Group type: EXPERIMENTAL
Intervention: Dopaminergic precursor
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dopamine receptor antagonist
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26739331

Group type: EXPERIMENTAL
Intervention: Sequential learning using a transparent shoebox for psychomotor skills followed by a box trainer for knot tying.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group learning using solely a box trainer with standard laparoscopic view.
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups receive a standardized introduction to the training center, laparoscopic instruments, and C‐loop technique.
Number of subjects: 54
Study: 25299806

Group type: EXPERIMENTAL
Intervention: Modified Network for Improvement of Addiction Treatment (NIATx) change team approach
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual approach to implement improved HIV services
Number of subjects: 0
Study: 22341703

Group type: EXPERIMENTAL
Intervention: Medication review by a pharmacist
Number of subjects: 323

Group type: COMPARATOR
Intervention: Usual health care (Control)
Number of subjects: 323
Study: 19811776

Group type: EXPERIMENTAL
Intervention: 50 mg d‐cycloserine
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 18030641

Group type: EXPERIMENTAL
Intervention: Lead poisoning preventive education
Number of subjects: 95
Study: 15642799

Group type: EXPERIMENTAL
Intervention: pioglitazone (30 mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: metformin (850 mg, three times a day)
Number of subjects: 34
Study: 11289292

Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel
Number of subjects: 34
Study: 9723669

Group type: EXPERIMENTAL
Intervention: 0.2% loteprednol etabonate
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 8039988

Group type: EXPERIMENTAL
Intervention: Ear-based temperature measurements using infrared thermometers
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rectal temperature measurements
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Axillary temperature measurements
Number of subjects: 30
Study: 2656908

Group type: EXPERIMENTAL
Intervention: Prednisone followed by alpha-interferon
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Interferon treatment
Number of subjects: 41

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 41
Study: 31327652

Group type: EXPERIMENTAL
Intervention: 4CMenB and MenC-CRM
Number of subjects: 0

Group type: COMPARATOR
Intervention: MenC-CRM
Number of subjects: 0
Study: 29141376

Group type: EXPERIMENTAL
Intervention: AGI grade I
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: AGI grade II
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: AGI grade III
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: AGI grade IV
Number of subjects: 80
Study: 25961614

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CRP levels
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: CRP test
Number of subjects: 60
Study: 23090093

Group type: EXPERIMENTAL
Intervention: Limaprost
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Limaprost plus NSAIDs
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Combination treatment (Limaprost + NSAIDs)
Number of subjects: 61
Study: 22158670

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamin C 120 mg, vitamin E 30 mg, beta-carotene 6 mg, selenium 100 μg, zinc 20 mg)
Number of subjects: 8112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8112
Study: 19496400

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system with acid etching and no attrition, no loading
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system with no attrition, with loading
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Self-etching adhesive system with attrition
Number of subjects: 8

Group type: COMPARATOR
Intervention: Self-etching adhesive system without attrition and acid-etching but with loading
Number of subjects: 8

Group type: COMPARATOR
Intervention: Self-etching adhesive system without attrition and loading but with acid etching
Number of subjects: 8
Study: 16689037

Group type: EXPERIMENTAL
Intervention: Psychiatric rehabilitation weight loss program (12 weeks)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Matched control group
Number of subjects: 36
Study: 15120937

Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study: 11168307

Group type: EXPERIMENTAL
Intervention: Infrared photosensors (PPG method)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Continuous wave Doppler (Doppler method)
Number of subjects: 181
Study: 10220218

Group type: EXPERIMENTAL
Intervention: Memory-training program involving computer-assisted teaching of imagery-based mnemonic strategies for recall of lengthy lists of words and for associating names with faces
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Memory-training program
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Memory training of those with MS
Number of subjects: 8
Study: 7824599

Group type: EXPERIMENTAL
Intervention: 40% sucrose solution
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (healthy age‐matched female controls)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Patients with a history of anorexia nervosa
Number of subjects: 40
Study: 2969799

Group type: EXPERIMENTAL
Intervention: urapidil (120 mg/day initially, increased to 180 mg/day if necessary)
Number of subjects: 29

Group type: COMPARATOR
Intervention: methyldopa (100 mg/day initially, increased to 1500 mg/day if necessary)
Number of subjects: 29
Study: 29241077

Group type: EXPERIMENTAL
Intervention: Ultrasound guided combined pectoral nerve blocks (PECS I and II) with general anesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 60
Study: 28733812

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 26299216

Group type: EXPERIMENTAL
Intervention: O‐SES (Orsiro)
Number of subjects: 2530

Group type: COMPARATOR
Intervention: N‐BES (Nobori)
Number of subjects: 2530
Study: 23787720

Group type: COMPARATOR
Intervention: Placebo arm of the EVEREST trial
Number of subjects: 1850
Study: 21382484

Group type: EXPERIMENTAL
Intervention: MMRV vaccine with a 4-week interval between doses (MMRV-4W)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: MMRV vaccine with a 12-month interval between doses (MMRV-12M)
Number of subjects: 559

Group type: COMPARATOR
Intervention: MMR vaccine with a 4-week interval between doses (MMR)
Number of subjects: 559
Study: 19035430

Group type: EXPERIMENTAL
Intervention: Training and surgical reconstruction
Number of subjects: 121

Group type: COMPARATOR
Intervention: Training only
Number of subjects: 121
Study: 16722837

Group type: EXPERIMENTAL
Intervention: Nonselective NSAIDs
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Aspirin users
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Antidiabetic medication
Number of subjects: 205
Study: 12057040

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1200 mg/m2 over 30 minutes on days 1 and 8 every 21 days plus trastuzumab 4 mg/kg over 90 minutes, followed by 2 mg/kg weekly.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Gemcitabine/trastuzumab treatment
Number of subjects: 38
Study: 10460066

Group type: EXPERIMENTAL
Intervention: 100 mg l-menthol capsule
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg menthol in mint candy or mint tea
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo administration
Number of subjects: 12
Study: 7796526

Group type: EXPERIMENTAL
Intervention: Soft contact lenses
Number of subjects: 85
Study: 1971650

Group type: EXPERIMENTAL
Intervention: 2 g CAZ administered 140 min prior to puncture (group I)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 2 x 2 g CAZ one day before and 2 g 2 h prior to puncture (group II)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CAZ concentrations at 4 h after infusion
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CAZ concentrations at 6 h after infusion
Number of subjects: 25
Study: 383133

Group type: EXPERIMENTAL
Intervention: BCG in weekly scarifications for 3 years
Number of subjects: 43

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 43
Study: 6639290

Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation group
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Self-help support group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 59

Group type: COMPARATOR
Intervention: Low-risk group (controls)
Number of subjects: 59
Study: 30005584

Group type: EXPERIMENTAL
Intervention: DBT skills training adjunctive to individual treatment as usual (TAU)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Individual treatment as usual (TAU) only
Number of subjects: 31
Study: 27029784

Group type: EXPERIMENTAL
Intervention: Behavioral distraction
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Cognitive avoidance
Number of subjects: 82
Study: 27437887

Group type: EXPERIMENTAL
Intervention: Ad5.hAC6 (3.2 × 10^9 to 10^12 virus particles)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad5.hAC6 (D4 + 5 doses)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ad5.hAC6
Number of subjects: 56